Search by Drug Name or NDC

NDC 68788-8143-01 Siltussin DM DAS Cough Formula 10; 100 mg/5mL; mg/5mL Details

Siltussin DM DAS Cough Formula 10; 100 mg/5mL; mg/5mL

Siltussin DM DAS Cough Formula is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

MedlinePlus Drug Summary

Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.

Related Packages: 68788-8143-01
Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Dextromethorphan

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Related Packages: 68788-8143-01
Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Guaifenesin

Product Information

NDC	68788-8143
Product ID	68788-8143_ef0b6ebd-071e-4f42-85d4-b97dbe097268
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Siltussin DM DAS Cough Formula
Proprietary Name Suffix	n/a
Non-Proprietary Name	Guaifenesin and Dextromethorphan Hydrobromide
Product Type	HUMAN OTC DRUG
Dosage Form	LIQUID
Route	ORAL
Active Ingredient Strength	10; 100
Active Ingredient Units	mg/5mL; mg/5mL
Substance Name	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Labeler Name	Preferred Pharmaceuticals Inc.
Pharmaceutical Class	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH FINAL
Application Number	part341
Listing Certified Through	n/a

Package

NDC 68788-8143-01 (68788814301)

Pricing Information	N/A
NDC Package Code	68788-8143-1
Billing NDC	68788814301
Package	118 mL in 1 BOTTLE, PLASTIC (68788-8143-1)
Marketing Start Date	2023-09-21
NDC Exclude Flag	N